DVAX

COVID-19 Vaccine (with Medicago)

COVID-19 Vaccine

Phase 1 (Preliminary safety and immunogenicity results)

Exp Date

October 2020 (Est)

Amp Volatility Score

Catalyst Info & Data Links

COMPETITORS

MECHANISM OF ACTION

  • CpG 1018 has been studied clinically and developed as a vaccine adjuvant for Dynavax’s hepatitis B vaccine, HEPLISAV-B. The pre-clinical and clinical studies demonstrate that the addition of CpG 1018 increases antibody concentrations, stimulates helper (CD4+) and cytotoxic (CD8+) T cell populations and generates robust T and B cell memory responses.

  • Adjuvants are a pharmacological or immunological substance that is combined with a specific protein (antigen) in a vaccine to help stimulate an immune response against the antigen. Some adjuvants work by stimulating specific immune pathways, such as toll like receptor 9 (TLR9), that promote stronger immune responses than with antigens alone.

  • Combining COVID-19 surface antigens with CpG 1018 for the vaccine to elicit a higher antibody titer. 

  • (Source)

Updated by MV

#COVID-19, #Dynavax, #CpG1018, #Coronavirus, #DVAX

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

DNVAX’s Hepatitis B Vaccine, H...

Heplisav-B, which was approved by the FDA in 2018, saw a large drop in sales in Q2 2020. The sales for Q2 2020 were $2.4M which is very low compared to Q1 2020 which was about $10.5M. Also, it is impo...

DVAX - Presenting Preliminary ...

DVAX is expecting to present their preliminary safety and immunogenicity results from Phase 1 COVID-19 studies in September and October 2020. See our AmpCard to learn more. #DVAX, #Dynavax, #COVID...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon